Vicarious Surgical (RBOT) Depreciation & Amortization (CF) (2020 - 2025)
Vicarious Surgical (RBOT) posted quarterly Depreciation & Amortization (CF) of $352000.0 for Q3 2025, down 30.57% year-over-year from $507000.0 in Q3 2024, and down 14.77% quarter-over-quarter from $413000.0 in Q2 2025.
Vicarious Surgical (RBOT) Depreciation & Amortization (CF) (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has reported Depreciation & Amortization (CF) for 6 consecutive years, with $352000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Depreciation & Amortization (CF) fell 30.57% year-over-year to $352000.0; the TTM figure through Dec 2025 stood at $1.1 million (down 45.85% YoY), while the FY2024 annual figure was $2.1 million, up 13.65% from the prior year.
- Depreciation & Amortization (CF) declined to $352000.0 in Q3 2025 per RBOT's latest filing, from $413000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $542000.0 in Q4 2024 and bottomed at $41000.0 in Q1 2021.
- Historically, Depreciation & Amortization (CF) has averaged $342473.7 across 5 years, with a median of $402000.0 in 2022.
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) surged 351.22% — and 2025, when it sank 30.57%.
- Vicarious Surgical's Depreciation & Amortization (CF) stood at $126000.0 in 2021, then jumped by 219.05% to $402000.0 in 2022, then surged by 30.6% to $525000.0 in 2023, then advanced by 3.24% to $542000.0 in 2024, then sank by 35.06% to $352000.0 in 2025.
- Business Quant data shows RBOT's Depreciation & Amortization (CF) at $352000.0 in Q3 2025, $413000.0 in Q2 2025, and $369000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Vicarious Surgical | 208,404.18 | -14.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 352,000.00 |
| Sep 30, 2025 | 352,000.00 |
| Jun 30, 2025 | 413,000.00 |
| Jun 30, 2025 | 413,000.00 |
| Mar 31, 2025 | 369,000.00 |
| Mar 31, 2025 | 369,000.00 |
| Dec 31, 2024 | 542,000.00 |
| Dec 31, 2024 | 542,000.00 |
| Sep 30, 2024 | 507,000.00 |
| Sep 30, 2024 | 507,000.00 |
| Jun 30, 2024 | 524,000.00 |
| Jun 30, 2024 | 524,000.00 |
| Mar 31, 2024 | 521,000.00 |
| Mar 31, 2024 | 521,000.00 |
| Dec 31, 2023 | 525,000.00 |
| Dec 31, 2023 | 525,000.00 |
| Sep 30, 2023 | 447,000.00 |
| Sep 30, 2023 | 447,000.00 |
| Jun 30, 2023 | 440,000.00 |
| Jun 30, 2023 | 440,000.00 |